Angelman Syndrome Pt. 4: Genetics and Epigenetics
See previous posts on history, symptoms, and neurophysiology of Angelman Syndrome.
The genetic and epigenetic lesions which lead to Angelman Syndrome (AS) have been studied in great detail and provide a window into the extraordinary complexity of genetic systems.
First, a review of the genetics (Butler 2009). Every cell in the body has two complete copies of the genome (with the exception of the sex chromosomes), 23 chromosomes from the father and 23 chromosomes from the mother. When chromosomes are passed on from parent to offspring, they are encoded with a distinct methylation pattern depending on if they are packaged in the egg (from the mother) or sperm (from the father). Methylation patterns arise from the action of DNA methyltransferases, which attach methyl groups (a carbon bound to three hydrogens) to cytosine nucleotides at specific places in the genome. Consequently, cells in the offspring ‘know’ which of each chromosome pair is from the mother or father. For most proteins, this methylation pattern does not matter – genes from both parents are expressed equally (this is called biallelic expression). For a subset of genes (~1%), however, only the maternally- or paternally-inherited allele is expressed. Gene imprinting represents a mechanism of gene regulation which does not originate in the animal’s genetic code and is thus an example of epigenetics.
The evolutionary significance of genomic imprinting is unknown. As parent-specific imprinting evolved in mammals about 150 million years ago, it has been hypothesized that imprinting arose from parental conflict: “Paternally expressed genes that increase the growth of the offspring, even at the expense of the mother, will increase the genetic fitness of the father. Conversely, maternally expressed genes that restrict resources provided to any one young, allowing her to carry successive pregnancies, will increase her genetic fitness” (Renfree et al 2009). In line with this theory, almost all imprinted genes identified thus far affect embryonic growth and nutrition. Further, imprinting is present in placental mammals and marsupials, but not the egg-laying monotremes. Imprinting also could have evolved as a mechanism to inhibit asexual reproduction and the subsequent deleterious effect of homozygous recessive mutations (Das et al 2009). It may allow the maternal and paternal chromosomes to specialize on different developmental transcription programs within cells, or it may have encouraged the mutation of new traits by enabling a single recessive mutation (on the active allele) to mediate a dominant phenotype. Last, genomic imprinting could have evolved as gene dosage became more important in cell physiology. This last theory comports with the recent acceleration of segmental genomic duplications during primate evolution (Marques-Bonet et al 2009).
Selective imprinted gene expression is especially common in the brain, and imprinted genes have been disproportionately linked to neuropsychiatric disorders (Butler 2009). Over 100 conditions have been associated with imprinting abnormalities, including Angelman syndrome, Prader-Willi syndrome, Silver-Russell syndrome, Beckwith-Wiedemann syndrome, Albright hereditary osteodystrophy, and uniparental disomy 14.
The q11-13 region of chromosome 15 contains a cluster of imprinted genes. Two of the genes, UbE3A and ATP10C, are maternally-expressed, meaning that only the maternally-inherited allele is active. 70% of Angelman syndrome cases are caused by a deletion of the maternally-inherited version of this chromosomal region, which leads to a lack of functional UbE3A and the symptoms of AS (Dan 2009). Another 5-10% of cases stem from an isolated deletion in the maternally-inherited UbE3A gene, and 3-5% of cases have an imprinting defect resulting in lack of the maternal pattern of DNA methylation required for UbE3A expression. 2-3% of cases are caused by uniparental disomy, a rare condition in which both copies of chromosome 15 are inherited from the father and none from the mother. 1-2% are due to complex genomic abnormalities which lead to the inactivation of UbE3A. In the remaining 10% of cases, etiology remains undetermined.
Although UbE3A disruption appears to be necessary for the symptoms of AS, it may not be sufficient. It is possible that isolated mutation of UbE3A only causes AS in concert with other mutations; this would explain why most cases are due to regional deletion, as many of the non-imprinted genes in the region, including three GABA receptor genes, have important roles in neural function and have been linked to neuropsychiatric disorders. Until a greater number of healthy control genomes are mapped, the prevalence of inactivating UbE3A mutations in the normal population will not be known.
Interestingly, inheritance of the same chromosome 15q11-13 deletion that causes AS, but from the father instead of the mother, causes a completely different disorder known as Prader-Willi syndrome (PWS) (Butler 2009). The most conspicuous phenotype of this disorder is an appetite so voracious that parents must put locks on the pantry and refrigerator. Perhaps as expected, PWS patients are almost unanimously obese. Other signs include mental retardation, hyperactivity, self-injury, short stature, small hands and feet, and characteristic facial features. At least a dozen genes in this region are paternally-expressed imprinted genes, including SNURF-SNPRN, NDN, MKRN3, MAGEL2, and several small nucleolar RNAs (snoRNAs – non-coding RNAs which guide the assembly of ribosomal RNA and transfer RNA (Bachellerie et al 2002)) . None of these genes by itself has yet been shown to be pathogenic for PWS.
A genome-wide microarray study of 859 autism spectrum syndrome (ASD) cases linked copy-number variations in UbE3A, along with three other ubiquitin-pathway genes (PARK2, RFWD2, and FBXO40), to autism (Glessner et al 2009). Eight ASD samples exhibited duplications in the 15q11-13 regions, compared to none of the control samples. In line with these findings, autistic features are actually disproportionately common in AS (1.9%) and PWS (25.3%) patients compared to the general population (~0.67%) (Veltman et al 2005).
The 15q11-13 region and UbE3A in particular are highly relevant to neuropsychiatric disorders. In the next section, I delve into UbE3A’s molecular biology to gain insight into AS pathogenesis.


